Cite Filings / AVLN / 0002149521-26-000002

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

Avalyn Pharma Inc. Filed 2026-08-11 Acc 0002149521-26-000002

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-08-14 SCHEDULE 13G Statement of Beneficial Ownership
2026-08-12 10-Q Quarterly Report
2026-08-12 8-K Results of operations
2026-08-11 SCHEDULE 13G Statement of Beneficial Ownership
2026-08-06 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-05-07 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…